Procuring Rs 650 Remdesivir at Rs 1568 during pandemic: FIR against pharma company Mylan for alleged Rs 6 crore fraud Farhat Nasim23 Oct 2023 12:54 PM ISTMumbai: Brewing controversy, the Mumbai Police's Economic Offences Wing (EOW) has filed an FIR against drug major Mylan Laboratories for alleged...
Physician, chemist may get confused due to common suffix 'KIND': HC on Mankind, Novakind trademark dispute Farhat Nasim15 Aug 2023 12:30 PM ISTNew Delhi: Observing that the marks "Novakind" and "Mankind" are confusing when applied to pharmaceutical products, the Delhi High Court has...
DoP rejects Intas Pharma submission against NPPA over Globucel M ceiling price Farhat Nasim28 Dec 2022 6:00 PM ISTNew Delhi: The Department of Pharmaceuticals (DoP) has rejected Intas Pharmaceuticals' plea against the National Pharmaceutical Pricing Authority...
Setback: HC rejects Sun Pharma plea against Hetero alleging trademark infringement of cancer drug Letroz Farhat Nasim6 Sept 2022 5:33 PM ISTNew Delhi: Holding that when the name is derived or coined from the name of the principal ingredient being used in the manufacture of the drug, no...
Alkem Labs secures CDSCO panel nod to conduct BE study of anti epileptic drug Farhat Nasim1 July 2022 6:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization (CDSCO) recommended for grant of permission...
COVID-19: 35 pharma cos to mass product generic version of Pfizer's Paxlovid MD Bureau18 March 2022 6:16 PM ISTIn India, Hyderabad-based pharma major Aurobindo Pharma has signed the agreement.
Purdue Pharma, US states agree to new opioid settlement Medical Dialogues Bureau6 March 2022 3:04 PM ISTNew Delhi: Purdue Pharma reached a nationwide settlement Thursday over its role in the opioid crisis, with the Sackler family members who own the...
Lupin launches Diagnostics Business in India Ruchika Sharma10 Dec 2021 4:57 PM ISTLupin is identifying franchisee partners who are willing to serve the needs of patients with a singular motto of 'Quality & Care'
Setback: Biogen loses bid to revive patent on Mylan blockbuster MS drug Tecfidera Ruchika Sharma3 Dec 2021 5:07 PM ISTTecfidera, on the market since 2013, has been key to Biogen's fortunes while it struggles to find new medicines to make up for declining revenue.
55 manufacturers to benefit under PLI scheme for pharma sector, says Govt Ruchika Sharma28 Nov 2021 9:00 AM ISTNew Delhi: The PLI Scheme for Pharmaceuticals is based on the strategy of "Atmanirbhar Bharat- Strategies for enhancing India's manufacturing...
US House panel approves fourth bill aimed at drug prices Ruchika Sharma2 Oct 2021 9:15 AM ISTWashington: The U.S. House Judiciary Committee voted Thursday to approve a fourth bill aimed at tackling high drug prices, approving a measure that...
Indian pharma ecosystem an example for others to follow, says Colombian envoy Ruchika Sharma19 Sept 2021 9:00 AM ISTNew Delhi: Ahead of the high-level delegation meeting between India and Colombia, the envoy of Colombia on Friday praised the Indian pharmaceutical...
